close
close

Interventional Cardiology and Peripheral Vascular Devices Market Projected CAGR of 7.2%

Posted on by darion

The global interventional cardiology and peripheral vascular devices market is expected to experience significant growth, with an estimated value of $34 billion by 2033 compared to $17 billion in 2023, reflecting a compound annual growth rate (CAGR) of 7. 2% from 2024 to 2024 2033. This increase is due to several factors, including the rising incidence of cardiovascular disease, advances in medical technology and a growing elderly population that is more susceptible to heart disease.

However, the market also faces challenges such as stringent regulatory requirements and complex reimbursement policies that can delay product approvals and increase development costs. Additionally, competition among key players is intensifying as companies strive to innovate and gain market share. Recent developments include the integration of digital health technologies such as remote monitoring and artificial intelligence that improve patient care and procedural outcomes. The North American region, with its advanced healthcare infrastructure and supporting policies, holds significant market share, while emerging markets offer lucrative growth opportunities due to improved economic conditions and healthcare awareness.

Key takeaways

  • The market size is expected to reach $34 billion by 2033, growing at approx CAGR of 7.2% from 2024 to 2033.
  • Coronary stents dominate 32% market share in 2023, essential for the treatment of cardiovascular diseases.
  • Hospitals are leading in the end-use segment and remain a leader 42% market share in 2023, followed by Ambulatory Surgery Centers.
  • The growing geriatric population is driving demand as older people are more susceptible to cardiovascular disease.
  • Strict regulatory processes increase development costs and delay product entry to market.
  • Digital integration is revolutionizing healthcare, with remote monitoring and AI algorithms improving patient care.
  • North America holds 37% market share in 2023, driven by advanced healthcare infrastructure and favorable policies.
  • Emerging markets offer growth opportunities due to economic progress and increasing awareness of cardiovascular disease.
  • Correction of congenital heart defects is a leading application segment with an increased demand for minimally invasive procedures.
  • Innovations in interventional cardiology and peripheral vascular devices are improving patient outcomes and driving market growth.

Download a sample report in PDF format: https://market.us/report/kardiologia-interwencyjna-and-periferacyjne-vascular-urząd-market/request-sample/

Key market segments for interventional cardiology and peripheral vascular devices

Product

  • Coronary stents
    • Drug-eluting stents
    • Bare stents
    • Bioabsorbable stents
  • Catheters
    • Angiography catheters
    • Guide catheters for percutaneous percutaneous coronary angioplasty
    • Intravascular ultrasound catheters
  • Guide wires for percutaneous percutaneous coronary angioplasty
  • Percutaneous balloons for percutaneous coronary angioplasty
  • Other product types

App

  • Correction of congenital heart defect
  • Angioplasty
  • Valvuloplasty
  • Percutaneous valve repair
  • Other applications

End use

  • Hospitals
  • Outpatient surgery centers
  • Other end uses

Key Regions

  • North America (USA, Canada, Mexico)
  • Western Europe (Germany, France, UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic countries, rest of Western Europe)
  • Eastern Europe (Russia, Poland, Czech Republic, Greece, rest of Eastern Europe)
  • APAC (China, Japan, South Korea, India, Australia and New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, rest of APAC)
  • Latin America (Brazil, Colombia, Chile, Argentina, Costa Rica, rest of Latin America)
  • Middle East and Africa (Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, rest of MEA)

Buy Directly: https://market.us/purchase-report/?report_id=33299

Analysis of key players

Abbott Laboratories is a leader in the interventional cardiology and peripheral vascular sector, offering a comprehensive portfolio of innovative and minimally invasive products. These include guidewires, balloon dilation catheters, and stent systems designed to treat peripheral arterial disease (PAD) and other venous conditions. Their extensive product portfolio addresses a variety of cardiovascular needs with an emphasis on advanced technologies such as the Supera Peripheral Stent System and the CardioMEMS HF System for the treatment of heart failure. Abbott’s commitment to innovation and patient care has made it a key player in improving cardiovascular health outcomes around the world.

B. Braun Melsungen AG offers a wide range of interventional cardiology and peripheral vascular devices with a focus on safety and effectiveness. The company offers products such as angioplasty catheters, stents and various vascular access devices. B. Braun emphasizes minimally invasive solutions that improve patient care and the effectiveness of procedures. Their portfolio includes advanced technologies designed to reduce complications and improve patient outcomes, making them a trusted name in the healthcare industry.

Cardinal Health is a significant player in the interventional cardiology and peripheral vascular market. The company supplies a wide range of key products, including catheters, stents and diagnostic tools. Cardinal Health’s offering is designed to support cardiovascular procedures, with an emphasis on quality and reliability. Their extensive distribution network provides healthcare providers with access to the devices needed for effective patient care, positioning them as a key partner in the healthcare supply chain.

Medtronic plc is renowned for its comprehensive portfolio of solutions in the interventional cardiology and peripheral vascular sector. Their product range includes angioplasty balloons, stents and endovascular aneurysm repair devices. Medtronic’s innovations, such as the Resolute Onyx drug-eluting stent, demonstrate its commitment to improving cardiovascular care. The company is focused on providing solutions that improve procedural outcomes and patient quality of life, maintaining a strong presence in global cardiovascular markets.

Boston Scientific Corporation is a leader in the development of cutting-edge interventional cardiology and peripheral vascular devices. Their broad product line includes stents, angioplasty balloons and atherectomy systems designed to treat complex cardiovascular conditions. Innovations such as the SYNERGY bioabsorbable polymer stent underscore the company’s focus on improving patient outcomes through advanced technology. Boston Scientific’s commitment to research and development ensures continued progress in the treatment of cardiovascular diseases, strengthening its position as a market leader.

Key players in the interventional cardiology and peripheral vascular devices market:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Cardinal’s health
  • Medtronic limited liability company
  • Boston Science Corporation
  • Cook medicine
  • Angiodynamics
  • CR Barda
  • Gore & Associates Inc
  • Teleflex Inc. WL
  • Other key players

Scope of the report on the interventional cardiology and peripheral vascular devices market >> Market value (2023): $17 billion || Projected revenues (2033): $34 billion || CAGR (2024–2033): 7.2% || Estimated base year: 2023 || Historical period: 2019-2022 || Forecast period: 2024-2033.

Ask more about the report: https://market.us/report/kardiologia-interwencyjna-and-periferacyjne-urząpowiedz-owani-market/#inquiry

About Market.US

Market.US is renowned for its comprehensive market research and analysis, providing customized and syndicated reports to clients around the world. Specializing in various sectors, they offer strategic insights and detailed market forecasts, helping companies make informed decisions. With a focus on innovation and accuracy, Market.US supports customers in over 126 countries and maintains a high percentage of repeat customers, emphasizing their commitment to quality and customer satisfaction. Their team specializes in providing exceptional research services, ensuring that no detail is overlooked in any target market.

Contact details
Market.us (operated by Prudour Pvt. Ltd.)
Contact number: +1 718 618 4351.
E-mail: [email protected]
Blog: https://medicalmarketreport.com/

See more trend reports

The hyaluronic acid knee injection market will grow by nearly $3.7 billion at a rate of 5.2% by 2033

Projected advanced glycation end-product market: $4.5 billion by 2033, growing at a CAGR of approximately 5.7%

The interventional cardiology and peripheral vascular devices market is projected to reach $34 billion by 2033, at approximately 7.2% CAGR

The Menkes syndrome market will reach $0.5 million by 2033 and grow at approximately 8.5% CAGR

The cardiovascular and soft tissue repair patch market is projected to reach $10.2 billion by 2033, at a CAGR of 8.5%